Latest Ewing's sarcoma Stories
Ewing’s sarcoma is a bone cancer commonly diagnosed in about 250 U.S. teenagers per year.
INDIANAPOLIS, May 27, 2011 /PRNewswire/ -- In the press release, "Lilly Presents Data on Cixutumumab in Five Subtypes of Sarcomas," issued May 19, 2011, by Eli Lilly and Company (NYSE: LLY), the following sentence has been amended to: The best overall responses were as follows: one partial response in the Ewing sarcoma tier (n=1); and no partial responses, but stable disease of 41 percent (n=9) in leiomyosarcoma; 35 percent (n=6) in synovial sarcoma; 28 percent (n=5) in Ewing family of...
INDIANAPOLIS, May 19, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced data from its Phase II study with cixutumumab in five subtypes of sarcoma, a cancer that develops from connective tissues in the body.
A drug developed to treat Ewing's Sarcoma, a rare childhood cancer, may also help prevent human prostate cancer from spreading.
Arsenic is usually thought of as a poison.
The first study of Ewing's sarcoma that screened hundreds of genes based on how they affect cell growth has identified two potential anti-cancer drug targets.
NEW YORK, April 29 /PRNewswire-USNewswire/ -- The Sarcoma Foundation of America (SFA)'s Eighth Annual Fundraising Gala on Monday, April 26, raised more than $925,000, an all-time record for the non-profit group dedicated to increasing research that will find new and better therapies for patients with sarcoma, a rare connective tissue cancer.
Ewing sarcoma (EWS) is a bone tumor of unknown cellular origin that affects children and young adults.
CALGARY, Nov. 6 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.
- Growing in low tufty patches.